Role of Autophagy and Reactive Oxygen Species in Cancer Treatment PDF Download

Author: Neeraj Mishra
Publisher: Springer Nature
ISBN: 3031664213
Category :
Languages : en
Pages : 372

View

Book Description

Author: Neeraj Mishra
Publisher: Springer
ISBN: 9783031664205
Category : Science
Languages : en
Pages : 0

View

Book Description
Autophagy is a catabolic process that eliminates damaged and faulty cellular components via lysosomes. It responds to adverse circumstances like nutritional deficiency, hypoxia, and oxidative damage. Reactive oxygen species (ROS) cause oxidative stress, which is a multidimensional chemical that drives various pathophysiological diseases, including cancer. In addition, the autophagy process has a double role, first preventing tumour formation, but later fostering tumour progression. A growing body of research suggests that autophagy and ROS have a complex interplay in which they can either prevent cancer growth or enhance disease genesis. While a combination of autophagy inhibitor and cytotoxic medicines is now being used in cancer treatment, investigating the potential of autophagy inhibitors for overcoming resistance to different anticancer medications and how this relates to the control of cancer micro environmental stressors raises several questions. Autophagy's dual functions as a safeguarding and cytotoxic process have drawn attention to its significance in the development of cancer.

Author: Noemí Rubio Romero
Publisher: Elsevier Inc. Chapters
ISBN: 0128069171
Category : Medical
Languages : en
Pages : 34

View

Book Description
Reactive oxygen species (ROS) have emerged as signaling molecules in pathways regulating cell growth and differentiation, inflammation, immune responses, survival, and death. ROS have been shown to promote autophagy, a lysosomal pathway for degradation of dysfunctional unnecessary cellular components. In fact, recent works have revealed a complex cross-talk between these intertwined signals. Whereas ROS can modulate autophagy activation in response to different types of stimuli, autophagy, in turn, may modulate ROS production by degrading, for example, dysfunctional mitochondria that generate aberrant amounts of ROS. Autophagy pathways can act both as tumor-promoter and tumor-suppressor mechanisms, with involvement of ROS in both cases. Paradoxically, whereas ROS and autophagy regulation may contribute to cancer initiation and progression, many antineoplastic treatments are precisely based on the massive production of ROS and activation of autophagy to induce cell death and eradication of diseased tissue. Nevertheless, autophagy activation has also shown a cytoprotective role against the efficiency of the therapy, and the mechanism that controls the switch between these two cellular functions in still unknown. In this chapter we will review the molecular mechanisms by which ROS modulate autophagy, and those modulated by autophagy to control ROS production, in the context both of cancer development and of cancer treatment.

Author: Paul C. Guest
Publisher: Springer Nature
ISBN: 303042667X
Category : Science
Languages : en
Pages : 340

View

Book Description
Aging is an inevitable part of life and is becoming a worldwide social, economic and health problem. This is mainly due to the fact that the increasing proportion of individuals in the advanced age category have a higher probability of developing age-related disorders, such as type II diabetes mellitus, cardiovascular disorders, sarcopenia, and neurodegenerative conditions. New therapeutic approaches are still needed to decrease or slow the effects of such diseases. Advances in -omic technologies, such as genomics, transcriptomics, proteomics and metabolomics, have significantly advanced our understanding of disease in multiple medical areas, as the analysis of multiple molecular networks has simultaneously provided a more integrated view of disease pathways. It is hoped that emerging hits from these analyses might be prioritized for further screening as potential novel drug targets for increasing the human healthspan in line with the lifespan. In turn, this will lead to new therapeutic strategies as well as drug development projects by the pharmaceutical industry. This book presents a series of reviews describing studies that have resulted in identification of new potential drug targets for age-related disorders. Much of this information has come from -omic comparisons of healthy and disease states or from testing the effects of new therapeutic approaches. Authored by experts from around the globe, each chapter is presented in the context of specific chronic diseases or therapeutic strategies. This book is designed for researchers in the areas of aging and chronic disease, as well as clinical scientists, physicians and stakeholders in major drug companies.

Author: Hsin-Yi Chen
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 128

View

Book Description
(Macro)autophagy is a catabolic process whereby intracellular components are enclosed into autophagosomes and delivered to lysosomes for degradation. Constitutive activity of autophagy contributes to turnover of proteins and organelles, ensuring the quality control of cellular components. Autophagy also can be induced by starvation or other stresses. This activity serves to provide internal resources to sustain metabolism and to prevent accumulation of detrimental substances. Therefore, autophagy is critical for cells to maintain homeostasis and to survive stress. Tumors are often subjected to metabolic stress due to insufficient vascularization. Autophagy is induced and localizes to these hypoxic regions where it supports survival. In aggressive tumors, the increased metabolic demand of rapid proliferation and growth may augment the dependency of cells on autophagy. In addition, autophagy that is induced by cancer therapy may be utilized by tumor cells for survival and be counterproductive to therapeutic efficacy. In this work, we tested the hypothesis that autophagy enables tumor cell survival and tumorigenesis in two different settings and addressed the underlying mechanism by which this occurs. First, we demonstrated that autophagy is required for viability in starvation and tumorigenicity of cells with oncogenic Ras activation. In these cells, defective autophagy caused abnormal mitochondria accumulation and reduced mitochondrial functionality in starvation associated with reduced energy charge. Since mitochondrial function is required for survival during starvation, we reasoned that autophagy supports survival and tumorigenicity of Ras-expressing cells by maintaining mitochondrial functionality. We also demonstrated that autophagy maintained mitochondrial function by preserving functional mitochondrial pools through mitophagy as well as by providing substrates for mitochondrial bioenergetic production under stress, thereby identifying autophagy and mitophagy as potential targets for treatment of cancers with oncogenic Ras activation. Second, we examined the significance of the mTOR inhibition-induced autophagy in counteracting the efficacy of the mTOR inhibitor CCI-779, which has shown temporary effectiveness in clinical treatment of human renal cell carcinoma. We demonstrated that mTOR inhibition promoted autophagy-mediated stress tolerance. Inhibition of autophagy with chloroquine enhanced the cytotoxicity of CCI-779 in vitro and in allograft tumors in mice. We further demonstrated that autophagy promoted cell survival in CCI-779-treated cells by providing alternative substrates for mitochondrial metabolism and suppressing reactive oxygen species production. This result justified a combination of autophagy inhibition with mTOR inhibitors in cancer therapy.

Author:
Publisher: Academic Press
ISBN: 0128241594
Category : Medical
Languages : en
Pages : 384

View

Book Description
Advances in Cancer Research, Volume 150, the latest release in this ongoing series, covers the relationship(s) between autophagy and senescence, how they are defined, and the influence of these cellular responses on tumor dormancy and disease recurrence. Specific sections in this new release include Autophagy and senescence, converging roles in pathophysiology, Cellular senescence and tumor promotion: role of the unfolded protein response, autophagy and senescence in cancer stem cells, Targeting the stress support network regulated by autophagy and senescence for cancer treatment, Autophagy and PTEN in DNA damage-induced senescence, mTOR as a senescence manipulation target: A forked road, and more. Addresses the relationship between autophagy and senescence in cancer therapy Covers autophagy and senescence in tumor dormancy Explores autophagy and senescence in disease recurrence

Author: Ying Tang
Publisher: Elsevier Inc. Chapters
ISBN: 0128069139
Category : Medical
Languages : en
Pages : 22

View

Book Description
Hyperglycemia refers to a condition in which an excessive amount of glucose circulates in the blood plasma. A wide range of evidence has proved hyperglycemia to be a great inducer of reactive oxygen species (ROS), through which various processes and signaling transduction cascades are activated or inhibited. Bursts of ROS can be produced by mitochondria, NADPH oxidase, and xanthine oxidase under hyperglycemia. These excessive ROS will further cause oxidative stress and contribute to the development of hyperglycemia complications. One of the downstream processes affected by redox imbalance is autophagy. Increasing evidence shows disturbed autophagy in cell lines treated with high glucose or in animals under hyperglycemia. The signaling pathways involved in are quite controversial, however. Here, we focus on the ROS-ERK/JNK-p53 pathway and discuss its potential role in activating autophagy in the condition of hyperglycemia.

Author: Salvatore Rizza
Publisher: Frontiers Media SA
ISBN: 2889456358
Category :
Languages : en
Pages : 183

View

Book Description
Living cells require a constant supply of energy for the orchestration of a variety of biological processes in fluctuating environmental conditions. In heterotrophic organisms, energy mainly derives from the oxidation of carbohydrates and lipids, whose chemical bonds breakdown allows electrons to generate ATP and to provide reducing equivalents needed to restore the antioxidant systems and prevent from damage induced by reactive oxygen and nitric oxide (NO)-derived species (ROS and RNS). Studies of the last two decades have highlighted that cancer cells reprogram the metabolic circuitries in order to sustain their high growth rate, invade other tissues, and escape death. Therefore, this broad metabolic reorganization is mandatory for neoplastic growth, allowing the generation of adequate amounts of ATP and metabolites, as well as the optimization of redox homeostasis in the changeable environmental conditions of the tumor mass. Among these, ROS, as well as NO and RNS, which are produced at high extent in the tumor microenvironment or intracellularly, have been demonstrated acting as positive modulators of cell growth and frequently associated with malignant phenotype. Metabolic changes are also emerging as primary drivers of neoplastic onset and growth, and alterations of mitochondrial metabolism and homeostasis are emerging as pivotal in driving tumorigenesis. Targeting the metabolic rewiring, as well as affecting the balance between production and scavenging of ROS and NO-derived species, which underpin cancer growth, opens the possibility of finding selective and effective anti-neoplastic approaches, and new compounds affecting metabolic and/or redox adaptation of cancer cells are emerging as promising chemotherapeutic tools. In this Research Topic we have elaborated on all these aspects and provided our contribution to this increasingly growing field of research with new results, opinions and general overviews about the extraordinary plasticity of cancer cells to change metabolism and redox homeostasis in order to overcome the adverse conditions and sustain their “individualistic” behavior under a teleonomic viewpoint.

Author: Keshav Singh
Publisher: Springer Science & Business Media
ISBN: 0387848355
Category : Medical
Languages : en
Pages : 294

View

Book Description
Nearly a century of scientific research has revealed that mitochondrial dysfunction is one of the most common and consistent phenotypes of cancer cells. A number of notable differences in the mitochondria of normal and cancer cells have been described. These include differences in mitochondrial metabolic activity, molecular composition of mitochondria and mtDNA sequence, as well as in alteration of nuclear genes encoding mitochondrial proteins. This book, Mitochondria and Cancer, edited by Keshav K. Singh and Leslie C. Costello, presents thorough analyses of mitochondrial dysfunction as one of the hallmarks of cancer, discusses the clinical implications of mitochondrial defects in cancer, and as unique cellular targets for novel and selective anti-cancer therapy.

Author: Gert-Jan L. Kaspers
Publisher: CRC Press
ISBN: 9783718653874
Category : Medical
Languages : en
Pages : 458

View

Book Description
The last ten years have seen the publication of a vast amount of data regarding cellular resistance to drugs in cancer cells. Recent studies have demonstrated that drug resistance assays appear to be predictive of clinical response and suggest that clinicians should now be considering the potential applications of these assays in the treatment of patients with hematological neoplasms. This collection of papers from the International Symposium on the Clinical Value of Drug Resistance Assays in Leukemia and Lymphoma, Amsterdam, 1992, provides a state-of-the-art discussion on drug resistance assays and their role in the design and individualization of treatment protocols.